Recently, B7 family members have attracted more attention, especially following the successful treatment in advanced melanoma, lung cancer, and other solid tumors with anti-PD1/PDL1 and anti-CTLA4 therapies (Sznol and Chen, 2013; Wolchok et al., 2013). The gene discussed is CTLA4; the disease is lung carcinoma.